Cargando…
Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice
Mucopolysaccharidosis type IIIB (MPS IIIB) or Sanfilippo Syndrome type B is a lysosomal storage disease resulting from the deficiency of N-acetyl glucosaminidase (NAGLU) activity. We previously showed that intracranial adeno-associated virus (AAV) -based gene therapy results in partial improvements...
Autores principales: | Heldermon, Coy D., Qin, Elizabeth Y., Ohlemiller, Kevin K., Herzog, Erik D., Brown, Jillian R., Vogler, Carol, Hou, Wei, Orrock, John L., Crawford, Brett E., Sands, Mark S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701029/ https://www.ncbi.nlm.nih.gov/pubmed/23535899 http://dx.doi.org/10.1038/gt.2013.14 |
Ejemplares similares
-
Development of Sensory, Motor and Behavioral Deficits in the Murine Model of Sanfilippo Syndrome Type B
por: Heldermon, Coy D., et al.
Publicado: (2007) -
Economic Burden of Sanfilippo Syndrome in the United States
por: Ashby, Frederick, et al.
Publicado: (2023) -
Mucopolysaccharidosis IIIB confers enhanced neonatal intracranial transduction by AAV8 but not by 5, 9 or rh10
por: Gilkes, J A, et al.
Publicado: (2016) -
Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice
por: Ashby, Frederick James, et al.
Publicado: (2023) -
Mucopolysaccharidosis type IIIB: a current review and exploration of the AAV therapy landscape
por: Rouse, Courtney J., et al.
Publicado: (2023)